Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 spike protein and RNA dependent RNA polymerase as targets for drug and vaccine development: A review
Yusuf Muhammed, Abduljalal Yusuf Nadabo, Mkpouto Pius, et al.
Biosafety and Health (2021) Vol. 3, Iss. 5, pp. 249-263
Open Access | Times Cited: 25

Showing 25 citing articles:

Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review
Paula Andrea Cuartas Velásquez, Juan C. Hernández, Elkin Galeano, et al.
Clinical Pharmacology Advances and Applications (2024) Vol. Volume 16, pp. 1-25
Open Access | Times Cited: 9
SARS-CoV-2 spike protein in infectivity
Alaa Muayad Altaie, Rania Hamdy, Mohamed I. Husseiny, et al.
Elsevier eBooks (2025), pp. 21-56
Closed Access
Novel Pyrrolidine-bearing quinoxaline inhibitors of DNA Gyrase, RNA polymerase and spike glycoprotein
Maha A. Ebrahim, Triveena M. Ramsis, Nirvana A. Gohar, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108218-108218
Closed Access
An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19)
Armina Alagheband Bahrami, Ali Azargoonjahromi, Samin Sadraei, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 27
Extracellular Vesicle‐Inspired Therapeutic Strategies for the COVID‐19
Ziwei Hu, Wei Wang, Ying Lin, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 29
Closed Access | Times Cited: 5
Towards a Safer Future: Enhancing Vaccine Development to Combat Animal Coronaviruses
Fusheng Si, Ruisong Yu, Shijuan Dong, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 330-330
Open Access | Times Cited: 4
The COVID-19 Oral Drug Molnupiravir Is a CES2 Substrate: Potential Drug-Drug Interactions and Impact of CES2 Genetic Polymorphism In Vitro
Yue Shen, William Eades, William Liu, et al.
Drug Metabolism and Disposition (2022) Vol. 50, Iss. 9, pp. 1151-1160
Open Access | Times Cited: 17
Comprehensive role of SARS‐CoV‐2 spike glycoprotein in regulating host signaling pathway
Shuvomoy Banerjee, Xinyu Wang, Shujuan Du, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4071-4087
Open Access | Times Cited: 14
A Comprehensive Overview of Sensors Applications for the Diagnosis of SARS-CoV-2 and of Drugs Used in its Treatment
Ahmet Çetinkaya, S. Irem Kaya, Síbel A. Özkan
Critical Reviews in Analytical Chemistry (2023) Vol. 54, Iss. 7, pp. 2517-2537
Closed Access | Times Cited: 5
Status, Problems and Challenges of Kaduna South L.G.A Nigeria on the Solid Waste Management in Unguwan Sanusi
Abubakar Sadiq Usman, Ibrahim Usman Bura
International Journal of Innovative Science and Research Technology (IJISRT) (2024), pp. 800-806
Open Access | Times Cited: 1
A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding
Jing Yang, Sheng Lin, Honglu Sun, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Salmonella-mediated oral delivery of multiple-target vaccine constructs with conserved and variable regions of SARS-CoV-2 protect against the Delta and Omicron variants in hamster
Khristine Kaith S. Lloren, Vijayakumar Jawalagatti, Chamith Hewawaduge, et al.
Microbes and Infection (2023) Vol. 25, Iss. 5, pp. 105101-105101
Open Access | Times Cited: 4
The effect of various compounds on the COVID mechanisms, from chemical to molecular aspects
Samira Mahmoudi, Mehrdad Mohammadpour Dehkordi, Mohammad Hossein Asgarshamsi
Biophysical Chemistry (2022) Vol. 288, pp. 106824-106824
Open Access | Times Cited: 7
Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses
Kun Zhang, Ke Wang, Chaoguo Zhang, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 6
SARS‐CoV‐2 main protease inhibitors: What is moving in the field of peptides and peptidomimetics?
Sergio Algar, M. Ángeles Bonache, Rosario González‐Muñiz
Journal of Peptide Science (2022) Vol. 29, Iss. 5
Open Access | Times Cited: 5
Towards the development of an epitope-focused vaccine for SARS-CoV-2
Jacquelynne Cervantes‐Torres, Sergio Rosales‐Mendoza, Carlos Cabello-Gutiérrez, et al.
Vaccine (2022) Vol. 40, Iss. 45, pp. 6489-6498
Open Access | Times Cited: 4
Designing an Epitope-Based Peptide Vaccine Derived from RNA-Dependent RNA Polymerase (RdRp) against Dengue Virus Serotype 2
Irma Febrianti Wahongan, Elly Juliana Suoth, Fatimawali Fatimawali, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1734-1734
Open Access | Times Cited: 4
Changes in new strains of the novel coronavirus interact with the environment
Ming Cheng, Puiwan Li, Yixuan Li
E3S Web of Conferences (2024) Vol. 553, pp. 05045-05045
Open Access
Monkeypox virus protein H3L induces injuries in human and mouse
Shaoxian Chen, Guiping Huang, Juli Liu
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access
Identification of anti-SARS-CoV-2 compounds from Qingwen Zhike prescription and exploration of their underlying mechanism by UPLC-Q-Exactive Orbitrap MS, high-throughput screening assays and transmission electron microscopy
Ping Zhao, Cai Zhang, Yue Che, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 255, pp. 116649-116649
Closed Access
Post COVID-19 effect of ovarian reserve
Abd El-Samie Abd El-Samie, Mohamed Etman
Fayoum University Medical Journal/Fayoum University Medical Journal (2023) Vol. 12, Iss. 1, pp. 60-68
Open Access | Times Cited: 1
Seeking antiviral drugs to inhibit SARS-CoV-2 RNA dependent RNA polymerase: A molecular docking analysis
Ibrahim Khater, Aaya Nassar
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0268909-e0268909
Open Access | Times Cited: 1
The prediction of SARS-CoV-2 main protease inhibition with filtering by position of ligand
Ya.O. Ivanova, A.I. Voronina, V.S. Skvortsov
Biomeditsinskaya Khimiya (2022) Vol. 68, Iss. 6, pp. 444-458
Open Access | Times Cited: 1
Generation of mRNA Vaccine: An Analysis of Two Types of Vectors
Goodluck Anthony Kelechi Ohanube, Uchejeso Mark Obeta
International Journal of Pharmaceutical and Phytopharmacological Research (2021) Vol. 11, Iss. 4, pp. 24-32
Open Access | Times Cited: 1
Development of SARS-COV-2 vaccines and their mechanisms of action: An approach to change the Africans perspectives on COVID-19 vaccines
Sunday Zeal Bala, N. Abdullahi, Madinat Hassan, et al.
Novel Research in Microbiology Journal (2021) Vol. 5, Iss. 5, pp. 1351-1370
Open Access
Page 1

Scroll to top